The Department of Health has started to dispense, in a phased manner, the continuous glucose monitoring devices to the patients with type 2 diabetes, insulin-dependent and who need at least six blood glucose controls per day, around 2,500 people in Catalonia.
The ‘conselleria’ will prioritize the distribution to the pregnant women or in pregnancy programming and to under the age of eighteen, according to a statement released Saturday.
This device is a device that measures glucose levels in the interstitial fluid in real time, providing information that contributes to “increase the quality of life of patients and caregivers”.
Currently in Catalonia, about 20,000 people with diabetes have one of these devices, which means coverage of the most at-risk diabetics, those with type 1 diabetes.